- Trials with a EudraCT protocol (472)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
472 result(s) found for: Rectum.
Displaying page 1 of 24.
EudraCT Number: 2006-001499-18 | Sponsor Protocol Number: 26/2006/O/Sper | Start Date*: 2006-05-12 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Radio-controlled Surgery RGS in the cancer of the rectum clinical study of feasibility to improve the treatment and prognosis | |||||||||||||
Medical condition: carcinoma of the rectum | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002727-11 | Sponsor Protocol Number: CRO-2020-043 | Start Date*: 2023-08-02 | |||||||||||||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO | |||||||||||||||||||||||
Full Title: Neoadjuvant Chemotherapy followed by Pre-operative Chemoradiation and Consolidation Chemotherapy before Surgery in High Risk Rectal Cancer: Multicentric Phase II Study. | |||||||||||||||||||||||
Medical condition: Patients with locally advanced, potentially resectable, Middle-Distal Rectal Carcinoma, stage T3c-d N1-2, MRF + or T4N0-2, EMVI - / + (High-Risk) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000722-24 | Sponsor Protocol Number: 8888 | Start Date*: 2005-07-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: PHASE II STUDY WITH CETUXIMAB SINGLE AGENT FOLLOWED BY 5-FU, CETUXIMAB AND PELVIC RADIOTHERAPY AS NEO-ADJUVANT TREATMENT FOR OPERABLE, LOCALLY ADVANCED RECTAL CANCER | |||||||||||||
Medical condition: CARCINOMA DEL TRATTO GASTROINTESTINALE, TESTA-COLLO | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003865-17 | Sponsor Protocol Number: CA209-7HJ | Start Date*: 2020-01-07 | ||||||||||||||||
Sponsor Name:Medizinische Universität Wien | ||||||||||||||||||
Full Title: Neoadjuvant CHemoradiotherapy with sequential Ipilimumab and NivOlumab in RECtal cancer (CHINOREC): a prospective randomized, open-label, multicenter, phase II clinical trial | ||||||||||||||||||
Medical condition: • Histologically confirmed carcinoma of the rectum • Suitable for local therapy with curative intent • Medical need for a standard neoadjuvant CRT • Suitable to withstand a course of standard neoad... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019233-97 | Sponsor Protocol Number: CARTS | Start Date*: 2010-10-18 | |||||||||||
Sponsor Name:University Medical Centre Nijmegen | |||||||||||||
Full Title: CHEMORADIOTHERAPY FOR RECTAL CANCER IN THE DISTAL RECTUM FOLLOWED BY ORGAN-SPARING TRANSANAL ENDOSCOPIC MICROSURGERY | |||||||||||||
Medical condition: T1-3 N0 M0 distal rectal tumor (below 10 cm), based on diagnostic imaging | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005475-14 | Sponsor Protocol Number: 1144 | Start Date*: 2005-10-17 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: INTEnsification Radiotherapy with Accelerated fractionation or ChemoTherapy And Local Excision After 3D External Radio-chemotherapy | |||||||||||||
Medical condition: rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011325-14 | Sponsor Protocol Number: 09-001 | Start Date*: 2009-08-11 | |||||||||||
Sponsor Name:Cliniques Universitaires Saint-Luc | |||||||||||||
Full Title: Phase II Study of Preoperative Panitumumab and External Beam Radiotherapy in Patients with Locally Advanced Rectal Cancer | |||||||||||||
Medical condition: Locally advanced adenocarcinoma of the rectum (T3 - T4 and/or N+ M0), previously untreated and non metastatic disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003697-52 | Sponsor Protocol Number: SYNCOPE-2021-V1 | Start Date*: 2020-09-16 | |||||||||||
Sponsor Name:Helsinki University Hospital | |||||||||||||
Full Title: Systemic Neoadjuvant and adjuvant Control by Precision medicine in rectal cancer (SYNCOPE) – approach on high-risk group to reduce metastases | |||||||||||||
Medical condition: Rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004406-25 | Sponsor Protocol Number: UC-0110/1005 | Start Date*: 2011-12-07 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001748-23 | Sponsor Protocol Number: SGM-LARRC | Start Date*: 2019-08-07 | ||||||||||||||||
Sponsor Name:Leiden University Medical Center | ||||||||||||||||||
Full Title: Multicenter, open-label, controlled, parallel arms clinical study on the performance of SGM-101, a fluorochrome-labeled anti-carcino-embryonic antigen (CEA) monoclonal antibody, for locally advance... | ||||||||||||||||||
Medical condition: Locally advanced rectal cancer Recurrent rectal cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001533-34 | Sponsor Protocol Number: 36/2007/O/Sper | Start Date*: 2007-04-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: A Phase II Study of Panitumumab 5-Fluorouracil and Oxaliplatin in combination with pelvic radiotherapy as treatment of resectable and locally advanced rectal cancer (StarPan Study ヨ STAR 02) | |||||||||||||
Medical condition: rectal carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002463-25 | Sponsor Protocol Number: N18TRZ | Start Date*: 2019-08-29 | |||||||||||
Sponsor Name:Antoni van Leeuwenhoek | |||||||||||||
Full Title: Neoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab (TARZAN) | |||||||||||||
Medical condition: adenocarcinoma of the rectum | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010093-38 | Sponsor Protocol Number: HyRec | Start Date*: 2012-08-15 | ||||||||||||||||||||||||||
Sponsor Name:Dekan of the Medical Faculty of the University Erlangen-Nuremberg; Prof. Dr. Dr. h. c. Jürgen Schüttler | ||||||||||||||||||||||||||||
Full Title: Multi-institutional Phase I/II Study: Neoadjuvant chemoradiation with 5-FU (or capecitabine) and oxaliplatin combined with deep regional hyperthermia in locally advanced or recurrent rectal cancer | ||||||||||||||||||||||||||||
Medical condition: Locally advanced primary or locally recurrent rectal cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005929-62 | Sponsor Protocol Number: H3E-MC-S077 | Start Date*: 2006-05-22 | |||||||||||
Sponsor Name:Eli Lilly and Company Limited | |||||||||||||
Full Title: A Feasibility study of Pemetrexed single agent and folic acid given as neoadjuvant treatment in patients with resectable rectal cancer | |||||||||||||
Medical condition: neoadjuvant treatment in chemo-naive patients with newly diagnosed operable rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000770-30 | Sponsor Protocol Number: IRST154.01 | Start Date*: 2013-07-10 | |||||||||||
Sponsor Name:IRCCS ISTITUTO SCIENTIFICO ROMAGNOLO PER LO | |||||||||||||
Full Title: Phase II study of up-front chemotherapy and neo-adjuvant short-course radiotherapy for resectable rectal carcinoma | |||||||||||||
Medical condition: resectable rectal carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001414-15 | Sponsor Protocol Number: REVOLUTION | Start Date*: 2018-07-27 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE TUMORI - IRCCS FONDAZIONE PASCALE | |||||||||||||
Full Title: Randomized phasE 2 study of Valproic acid in combination with bevacizumab and Oxaliplatin/fLUoropyrimidine regimens in patients with ras-mutated metastaTIc cOlorectal caNcer | |||||||||||||
Medical condition: patients with ras-mutated metastaTIc colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000217-30 | Sponsor Protocol Number: IRINOX | Start Date*: 2008-02-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Treatment with Oxaliplatin and Irinotecan in colorectal metastatic tumors with high expression of thymidilate synthase (TS). | |||||||||||||
Medical condition: PATIENTS WITH METASTATIC COLORECTAL CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005661-11 | Sponsor Protocol Number: XELOXART | Start Date*: 2006-03-30 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: PHASE II STUDY OF NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER | |||||||||||||
Medical condition: rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009277-10 | Sponsor Protocol Number: NCT-2008-11-02-1021 | Start Date*: 2011-03-24 | |||||||||||
Sponsor Name:University Hospital Heidelberg | |||||||||||||
Full Title: Neoadjuvant Radiochemotherapy Combined with Panitumumab in Locally Advanced KRAS wild-type Rectal Cancer | |||||||||||||
Medical condition: Histologically confirmed, potentially resectable rectal adenocarcinoma staged as uT3/4, N0/1 by endosonography or cT3/4 by MRI of the pelvis with or without local lymph node metastases, but without... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000802-30 | Sponsor Protocol Number: ML18522 | Start Date*: 2005-09-15 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: Phase II study of the combination of Bevacizumab (rhuMab VEGF) plus Capecitabine with pre-operative standard radiotherapy in patients with locally advanced rectal cancer. | |||||||||||||
Medical condition: Patients with locally advanced, non metastatic, resectable primary rectal cancer stage cT3 or cT4 who are subject to combined chemotherapy of the pelvic region in the pre-operative setting. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.